New technologies and adaptations of existing technologies can improve platform processes.
Erin Miller-Cary
Advertisement
Erin Miller-Cary is a senior associate scientist at Pfizer BioTherapeutics Research and Development
Articles by Erin Miller-Cary
Advertisement
Latest Updated Articles
Advances in Monoclonal Antibody PurificationPublished: March 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
